In vivo functional screening via CRISPR-Cas9 to systematically identify cardiomyocyte receptors as targets for the innovative therapies for myocardial infarction and heart failure

Project: Research

Project Details

AcronymR-FunSel
StatusFinished
Effective start/end date1/04/201931/03/2021

Funding

  • EC European Commission: £178,864.00